je.st
news
Sigma Life Science Licenses CompoZr Zinc Finger Nuclease Technology to Horizon Discovery
2013-09-03 06:00:00| Industrial Newsroom - All News for Today
Horizon to utilize both nuclease and rAAV gene editing platforms in custom cell-line generation services and creation of genetically-defined cell line products<br /> <br /> ST. LOUIS -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) today announced that Sigma® Life Science, its innovative biological products and services business, has entered a non-exclusive license agreement with Horizon Discovery for use of Sigma's CompoZr® Zinc Finger Nuclease (ZFN) technology. The agreement gives Horizon the ...This story is related to the following:ServicesSearch for suppliers of: Genetic Engineering
Tags: life
technology
science
discovery
Category:Industrial Goods and Services
Latest from this category |
All news |
||
|